Article PDF
Avoid common mistakes on your manuscript.
References
Bhat CS, Gupta L, Balasubramanian S, Singh S, Ramanan A V. Hyper inflammatory syndrome in children associated with COVID-19: Need for awareness [published online ahead of print, 2020 Jul 15]. Indian Pediatr. 2020; S097475591600208.
Henderson LA, Canna SW, Friedman KG, et al. American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with SARS-CoV-2 and Hyper Inflam-mation in COVID-19. Version 1 [published online ahead of print, 2020 Jul 23]. Arthritis Rheumatol. 2020;10.1002/art.41454.
Li H, Chen K, Liu M, Xu H, Xu Q. The profile of peripheral blood lymphocyte subsets and serum cytokines in children with 2019 novel coronavirus pneumonia. J Infect. 2020;81:115–20.
Shulman ST. Pediatric coronavirus disease-2019-associated multisystem inflammatory syndrome. J Pediatric Infect Dis Soc. 2020;9:285–6.
Cortegiani A, Ippolito M, Greco M, et al. Rationale and evidence on the use of tocilizumab in COVID-19: A systematic review. Pulmonol. 2020;S2531-0437:30153–7.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sood, M., Sharma, S. Multisystem Inflammatory Syndrome in Children (MIS-C) — Recent Updates. Indian Pediatr 57, 978–979 (2020). https://doi.org/10.1007/s13312-020-2016-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-020-2016-2